I agree that this site is using cookies. You can find further informations here.
X
Al-Roughani, Raed
8  results:
Search for persons X
?
1

Safety and Efficacy of Disease Modifying Therapies After Sw..:

Zeineddine, Maya ; Al-Roughani, Raed ; Khoury, Samia...
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105299 , 2023
Link: https://doi.org/10.1016/..
 
?
2

The Adherence and Clinical Outcomes in Patients with Relaps..:

Al-Roughani, Raed ; Zakaria, Magd ; Cupler, Edward J.
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105318 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Disease-Modifying Therapies, Outcomes, Risk Factors and Sev..:

Zeineddine, Maya ; Boumediene, Farid ; Al-Hajje, Amal...
Multiple Sclerosis and Related Disorders.  71 (2023)  - p. 104369 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Adherence to subcutaneous interferon beta-1a treatment amon..:

Al-Roughani, Raed ; Zakaria, Magd ; Cupler, Edward J..
Frontiers in Neurology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
5

Clinical trials of disease-modifying agents in pediatric MS..:

Waubant, Emmanuelle ; Banwell, Brenda ; Wassmer, Evangeline...
Neurology.  92 (2019)  22 - p. , 2019
Link: https://doi.org/10.1212/..
 
?
6

The Association of Vitamin D Receptor Polymorphisms with Mu..:

Al-Temaimi, Rabeah Abbas ; Al-Enezi, Anwar ; Al-Serri, Ahmad...
PLOS ONE.  10 (2015)  11 - p. e0142265 , 2015
Link: https://doi.org/10.1371/..
 
?
7

Adherence to subcutaneous interferon beta-1a treatment amon..:

Al-Roughani, Raed ; Zakaria, Magd ; Cupler, Edward J.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10713779/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

Rebound of Multiple Sclerosis Disease Activity After Switch..:

Inshasi, Jihad ; Roughani, Raed Al ; Shamali, Sara Ali Al...
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105335 , 2023
Link: https://doi.org/10.1016/..
 
1-8